This secondary analysis is based on the data from the Study of Pharmacotherapy for Psychotic Depression ( STOP-PD ) in which @ participants meeting DSM-IV criteria for MDD with psychotic features enrolled between December @ and June @ ( including @ aged @ years ) in a @-center , @ - week , double-blind , randomized controlled trial funded by the US National Institutes of Health .